Participants 10 113 5
desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis
Participants 258 367 4
there have been no controlled clinical trials to evaluate its systemic safety when used in treating children.
Participants 748 889 4
the comparative effects of 0.05 percent desonide and 2.5 percent hydrocortisone ointments on the HPA axis of children with atopic dermatitis.
Participants 1150 1313 3
0.05 percent desonide ointment nor 2.5 percent hydrocortisone ointment compromised the HPA axis of children with atopic dermatitis treated topically for four weeks
